We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Outlines Sponsor Scenarios For Subgroup Enrichment Trials
EMA Outlines Sponsor Scenarios For Subgroup Enrichment Trials
Sponsors may be asked to provide the European Medicines Agency with additional data from failed trials to hone in on subpopulations where the treatment may be effective.